Recent Quotes (30 days)

You have no recent quotes
chg | %

Luminor Medical Technologies Inc  

(Public, CVE:LMT)   Watch this stock  
Find more results for CVE:MOM
0.205
+0.005 (2.50%)
Jun 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.17 - 0.22
52 week 0.14 - 0.75
Open 0.22
Vol / Avg. 27,000.00/55,258.00
Mkt cap 1.71M
P/E     -
Div/yield     -
EPS -0.44
Shares 9.37M
Beta 0.09
Inst. own     -

Key stats and ratios

Q1 (Feb '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -368.58% -272.15%
Return on average equity - -
CDP Score - -

Address

C/O CRIS Inc. Suite 217, B2-125 the Queensway
ETOBICOKE, ON M8Y 1H6
Canada
+1-647-2254337 (Phone)
+1-204-4531546 (Fax)

Website links

Description

Luminor Medical Technologies Inc., formerly Miraculins Inc., is a Canada-based medical diagnostic company. The Company is focused on acquiring, developing and commercializing non-invasive technologies for various clinical needs. It offers Scout DS device, which is a clinical tool to assist in the identification of both pre-diabetes and type 2 diabetes, and is a non-invasive testing system that provides a method for measuring pre-diabetes/type 2 diabetes related biomarkers in the skin. The Company is in various stages of development of diagnostic and risk assessment products.

Officers and directors

Harry J F Bloomfield Independent Chairman of the Board
Age: 70
Christian Sauvageau President, Chief Executive Officer, Director
Christopher A. Carmichael CPA Chief Financial Officer
Daniel Cloutier Director
Ashwath Mehra Director